SCHEMBL3914828

SCHEMBL3914828

CNc1ccc(CN2CC[N+](C(=O)[O-])(C(C)(C)C)[C@@H](C)C2)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
TP53 P04637 3/20 0.36
PKM P14618 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MLNR O43193 3/20 0.34
RAB9A P51151 2/20 0.34
CYP3A4 P08684 2/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR5 Q9H228 1/20 0.33
ROCK2 O75116 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921081 0.86 DRD2 (0.40) DRD2DRD4KDM4EALDH1A1S1PR1
SCHEMBL3912115 0.86 DRD2 (0.40) DRD2DRD4KDM4EALDH1A1S1PR1
SCHEMBL4597553 0.86 SMN1; SMN2 (0.39) DRD2DRD4KDM4EALDH1A1RAB9A
SCHEMBL3911225 0.85 MLNR (0.34) DRD2DRD4TP53MLNRS1PR1
SCHEMBL3914146 0.84 KDM4E (0.46) KDM4EALDH1A1RAB9AMAPTNPC1
SCHEMBL3912803 0.84 KDM4E (0.46) KDM4EALDH1A1RAB9AMAPTNPC1
SCHEMBL3924819 0.84 CNR2 (0.37) DRD2DRD4
SCHEMBL3920606 0.84 HIF1A (0.35)
SCHEMBL3932724 0.83 ALDH1A1 (0.35) ALDH1A1POLBHRH3
SCHEMBL3936339 0.83 EPHX2 (0.37) DRD2DRD4KDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041093-A1 PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES Glaxo Group Limited (GB) 2009-04-01 EP disclosed
EP-2029538-A1 BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS Glaxo Group Limited (GB) 2009-03-04 EP disclosed
WO-2008000729-A1 PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2008-01-03 WO disclosed
WO-2007144400-A1 BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2007-12-21 WO disclosed